Industry Briefs April 2022 | PM360

Collaboration Aims to Revolutionize Vaccine Development The physIQ Sensor System is a medical-grade biosensor that will be used as part of a new study examining vaccination responses. physIQ, a pioneer in digital medicine, and CellCarta, a global contract research organization (CRO) specializing in precision medicine services, announced a partnership on a study to monitor individual … Read more

Pfizer Rejects Accusations it Infringed COVID-19 Vaccine Assay Technology

“’The alleged patent infringement—asserted uses by Pfizer and BioNTech of the patented invention to generate data from clinical trials in support of seeking FDA approval—are precisely the type of activity that is protected by the ‘safe harbor’ from patent infringement claims under 35 USC § 271(e)(1).”’ – Pfizer Memorandum on Motion to Dismiss Pfizer and … Read more

What now? Alzheimer’s drugmakers ponder the path to approval

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Last week, Medicare rendered a fateful decision that’s become the latest flashpoint in Biogen’s ongoing saga with Aduhelm. As part of a new finalized policy, the Centers for Medicare and Medicaid Services (CMS) will limit coverage for … Read more

Industry Comments on Proposed Changes to Bayh-Dole Regulations Zero in on March-In Language

“Skeptics mistakenly believe – on purpose – that Bayh-Dole should be used as part of a price control regime to lower drug prices…. No one likes to pay high prices, of course. So, why not just have the federal government mandate price controls? They seem to think innovation will continue to happen even though profit … Read more

Test to Treat: pharmacists say Biden’s major new Covid initiative won’t work | Coronavirus

A major new Biden administration initiative to facilitate access to Covid-19 antivirals will have a limited impact and fail to mitigate certain health inequities, major pharmacist groups argue, because pharmacists are restricted from prescribing the pills. Announced in Joe Biden’s State of the Union address, the “Test to Treat” program is meant to address the … Read more

Healthcare Watch April 2022 | PM360

Doctor Docs: Physicians are Fed Up with COVID-19 Misinformation According to a Sermo survey, 81% of physicians say social media misinformation has caused an existential crisis in their profession. Around the world, 55% of physicians are saying that COVID vaccine misinformation is-19 becoming an issue when meeting with patients, according to a Sermo survey of … Read more

With Lilly on board, Entos’ medical chief champions genetic platform with ‘unlimited’ potential

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Entos Pharmaceuticals is on the verge of “leveling up,” and Steve Chen is excited to help them get there. “I think the company right now is actually going through what I would call a major inflection point,” … Read more

House Committee Targets AbbVie Patent Practices, Urges FTC to Investigate

“It took 155 years for the USPTO to issue its first 5 million patents in 1991; it has taken less than 1/5 of that time to issue the next 6 million. Have we really become more inventive in the last 30 years or have we just got better at inventing patents?” Tamir Amin, Initiative for … Read more

Two Key Questions About Payer Strategies in 2022

PM360 We asked experts in dealing with payers to tell us the optimal strategies for negotiating pricing and formularies and the continued push toward value-based models. Specifically, we wanted to know: What are the keys to successful payer-pharma negotiations in 2022? What data do payers most value from pharma? How are the other needs or … Read more

Oxford Covid jab gears up for final act: saving the rest of the world | Vaccines and immunisation

Exactly two years ago Prof Sir Andrew Pollard was starting to panic. “We were just waking up to the reality of Covid-19 and that we would need vaccines for our very survival,” the director of the Oxford Vaccine Group told the Guardian last week. He joined forces with a colleague, Prof Dame Sarah Gilbert, and … Read more